Medtronic has launched the Enlite Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in the UK combining greater comfort with improved glucose sensor performance in both overall accuracy and hypo detection.
When the Enlite Sensor is used with the predictive alerts feature on Medtronic systems MiniMed Paradigm REAL-Time System, MiniMed Paradigm Veo System), diabetes patients have access to hypo detection rates up to 98%. This helps give early warning to people with diabetes so they can take action to prevent having hypos.
“The Enlite Sensor will improve patients’ ability to predict and detect hypoglycemia, which can be one of the most frightening aspects of living with Type 1 diabetes,” comments Prof. Peter Hindmarsh, Professor of Paediatric Endocrinology at University College London. “CGM is an important element in managing diabetes. The STAR 3 trial demonstrated that diabetes patients achieved better glucose control when sensors were integrated with insulin pump therapy compared to multiple daily injections. Moreover, other recent studies continue to suggest that the more often patients use CGM, the greater average glucose control they can achieve without increasing hypoglycemia.”
Significant design improvements make Enlite Sensor more comfortable and easier to use than the previous sensor with an easy-to-use insertion device that hides the necessary needle used to pierce the skin to get the sensor on the body. The needle is not only out of sight, it also retracts after use so that there’s no chance of accidental injuries – it’s also significantly smaller than the needle used in previous models. The Enlite Sensor itself is also significantly smaller sensor compared to Medtronic’s previous product – about half the size. The sensor comes complete with additional adhesive patches to hold it in place so that overall it will be more secure and lead to less irritation at the site.
“The adoption of CGM is growing rapidly, as both diabetes patients and their diabetes care professionals experience the benefits of seeing fluctuations in glucose patterns so that action can be taken to achieve better diabetes control. By making the new Enlite Sensor smaller, as well as easier to insert and wear, we expect that more people with diabetes will be able to utilize this technology to manage their condition and ultimately improve their lives,” said Katie Szyman, president of the Diabetes business and senior vice president at Medtronic.
http://www.medtronic-diabetes.co.uk/healthcare-professionals/index/enlite-sensor.html
